Filgrastim Injection IP PFS 300 Mcg Recombinant Human Granulocyte Colony Stimulation Factor Injection

Get a Price/Quote

MOQ : 100 Packs

Filgrastim Injection IP PFS 300 Mcg Recombinant Human Granulocyte Colony Stimulation Factor Injection Specification

Life Span
24 months from manufacturing date

Dosage Form
Parenteral

Indication
Neutropenia, bone marrow transplantation, and chemotherapy-induced neutropenia

Packaging Type
Pre-Filled Syringe (PFS)

Pacakaging (Quantity Per Box)
1 syringe per box

Origin of Medicine
India

Salt Composition
Filgrastim 300 mcg

Brand Name
Filgrastim Injection IP

Drug Type
Biological

Ingredients
Recombinant Human Granulocyte Colony Stimulating Factor (Filgrastim) 300 mcg

Physical Form
Injection

Function
Boost white blood cell count

Recommended For
Prevention of neutropenia in patients undergoing chemotherapy

Dosage
As directed by the physician

Dosage Guidelines
Administer subcutaneously or intravenously as per medical supervision

Suitable For
Adults and pediatric patients as prescribed

Quantity
1 pre-filled syringe

Storage Instructions
Store between 2C to 8C. Do not freeze.

Prescription Required
Yes

Marketed By
As mentioned on packaging

Manufacturing License No.
As mentioned on packaging

Route of Administration
Subcutaneous or intravenous use

Common Side Effects
Bone pain, fever, injection site reactions

Use in Pregnancy and Lactation
Use only if prescribed by your doctor

Precautions
Not to be used in patients with hypersensitivity to filgrastim or E. coli derived proteins

Appearance
Clear, colorless solution

Filgrastim Injection IP PFS 300 Mcg Recombinant Human Granulocyte Colony Stimulation Factor Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Filgrastim Injection IP PFS 300 Mcg Recombinant Human Granulocyte Colony Stimulation Factor Injection

Get the champion of white blood cell support with Filgrastim Injection IP PFS 300 Mcg. This sterling, cost-effective medicine offers unparalleled efficacy for the prevention of neutropenia in patients receiving chemotherapy or undergoing bone marrow transplantation. Each box contains a single pre-filled syringe of a clear, colorless solution to be administered subcutaneously or intravenously under medical supervision. This hot deal ensures both adults and pediatric patients benefit from a reliable boost in white blood cells. Prescription required. Store between 2C and 8C.

Sterling Features and Applications

Filgrastim Injection IP PFS 300 Mcg boasts a clear, colorless solution with champion performance in neutropenia management. Its unparalleled formulation, featuring Recombinant Human Granulocyte Colony Stimulating Factor, is indicated for use in patients undergoing chemotherapy, bone marrow transplantation, or those at risk for chemotherapy-induced neutropenia. With a pre-filled syringe ensuring ease of use and precise administration, this parenteral injection is ideal for both adults and pediatric patients as directed by a physician.

Export Markets, Supply, and Ordering Process

Recognized in major export markets, Filgrastim Injection IP PFS 300 Mcg has robust supply ability and flexible sample policy for distributors and healthcare providers. Order processing is seamless and tailored to meet bulk requirements, with attractive proposal amounts linked to list prices and quantity per box. Reliable delivery ensures medical facilities receive products promptly, supporting uninterrupted patient care.

FAQ's of Filgrastim Injection IP PFS 300 Mcg Recombinant Human Granulocyte Colony Stimulation Factor Injection:

Q: How should Filgrastim Injection IP PFS 300 Mcg be administered?

A: Filgrastim Injection IP PFS 300 Mcg should be administered either subcutaneously or intravenously, strictly as per the dosage and guidelines provided by your physician.

Q: What is the primary benefit of using Filgrastim Injection IP PFS 300 Mcg?

A: The main benefit is the prevention and management of neutropenia, particularly in patients undergoing chemotherapy or bone marrow transplantation, by boosting white blood cell count.

Q: When should Filgrastim Injection IP PFS 300 Mcg be used during pregnancy or lactation?

A: This injection should only be used during pregnancy or lactation if prescribed by your doctor, after careful consideration of the potential benefits and risks.

Q: Where should Filgrastim Injection IP PFS 300 Mcg be stored?

A: Store the pre-filled syringe in a refrigerator between 2C and 8C. It should not be frozen and must be kept away from light until use.

Q: What precautions should be taken before administering this injection?

A: Filgrastim Injection IP PFS 300 Mcg must not be used in patients with known hypersensitivity to filgrastim or E. coli-derived proteins. Consult your healthcare provider for a full list of precautions.